EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, Indonesia

Bony Wiem Lestari iD, Silvi Indriani iD, Adriana Viola Miranda, Dyah Ayu Nur Safira iD, Nur Ayu Fitriani, Raden Desy Nurhayati, Mirza Purwitasari, Almira Alifia, Alamanda Larasmanah, Iceu Dimas Kulsum, Arto Yuwono Soeroto

PLOS One · 01.07.2026 · 21 (7) · e0352658

DOI: 10.1371/journal.pone.0352658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.07.2026. Verfasst von Bony Wiem Lestari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Health Expenditures. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Leadership Grant Universitas Padjadjaran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People with drug-resistant tuberculosis (DR-TB) experience multiple visits to healthcare providers before DR-TB diagnosis and treatment. Our study aimed to quantify pretreatment direct costs and factors associated with higher costs among people with DR-TB.

Methods

Our cross-sectional study aimed to recruit 300 adults with pulmonary DR-TB from three DR-TB referral centers in Bandung, Indonesia, between February 2023 and February 2024. Participants were interviewed using a structured questionnaire regarding their demographic characteristics and out-of-pocket costs for the following categories: administration, chest radiography, laboratory tests, medication, travel, food, and other non-medical costs. Pretreatment out-of-pocket costs were analyzed descriptively, and factors influencing higher costs were examined using quantile regression. Costs were presented in U.S. dollars (USD, $) and reported as medians and interquartile ranges (IQRs).

Results

Among 258 eligible participants, 57.4% were male; median age was 38 years (IQR 27–47.7). A higher proportion of patients resided in rural areas (68.6%) and had initial visits to community health center (CHC) for TB-related symptoms (53.1%). The median pretreatment direct costs (excluding hospitalization) per person were estimated at $44.6 (IQR 18.8–92.7). The major contributors of pretreatment costs per person included hospitalization ($67.3), travel expenses ($13.7), chest radiography ($11.2), and medication ($10.8). Factors associated with greater pretreatment costs were residing in a rural area [β = 17.9, (95% CI: 1.07, 34.93)], had ≥ 7 visits to a healthcare provider [β = 19.9, (95% CI: 3.12, 36.74)], and their first TB symptom-related visit was to a private hospital [β = 38.7, (95% CI: 8.20, 69.30)], public hospital [β = 35.7, (95% CI: 8.60, 62.77)] and private primary care [β = 37.9, (95% CI: 19.36, 56.54)], compared to a community health center.

Conclusions

People with DR-TB in Indonesia incurred incremental direct costs during the pretreatment phase. Strengthening TB diagnostic infrastructure and sample referral networks between public and private providers in rural areas is critical to reducing the extra visits and financial burden for DR-TB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantHealth ExpendituresHumansIndonesiaFemaleMaleAdultCross-Sectional StudiesMiddle AgedAntitubercular AgentsHealth Care Costs

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia.
  • Tuberculosis Working Group, Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, Indonesia.
  • Department of Internal Medicine, Dr. H. A. Rotinsulu Pulmonary Hospital, Bandung, West Java, Indonesia.
  • Community Lung Health Center, Bandung, West Java, Indonesia.
  • Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.
  • Department of Internal Medicine, Division of Respirology and Critical Care Medicine, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.

ORCID-Profile: Bony Wiem Lestari, Silvi Indriani, Dyah Ayu Nur Safira

Förderung

  • Academic Leadership Grant Universitas Padjadjaran

Zitieren

APA

Lestari, B. W., Indriani, S., Miranda, A. V., Safira, D. A. N., Fitriani, N. A., Nurhayati, R. D., Purwitasari, M., Alifia, A., Larasmanah, A., Kulsum, I. D., & Soeroto, A. Y. (2026). Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, Indonesia. PLOS One, 21(7), e0352658. https://doi.org/10.1371/journal.pone.0352658

Vancouver

Lestari BW, Indriani S, Miranda AV, Safira DAN, Fitriani NA, Nurhayati RD, et al. Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, Indonesia. PLOS One. 2026;21(7):e0352658. doi:10.1371/journal.pone.0352658

BibTeX
@article{Lestari2026,
  author = {Lestari, Bony Wiem and Indriani, Silvi and Miranda, Adriana Viola and Safira, Dyah Ayu Nur and Fitriani, Nur Ayu and Nurhayati, Raden Desy and Purwitasari, Mirza and Alifia, Almira and Larasmanah, Alamanda and Kulsum, Iceu Dimas and Soeroto, Arto Yuwono},
  title = {Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, Indonesia},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0352658},
  doi = {10.1371/journal.pone.0352658}
}
Kostenlos starten →